Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Conditions: Breast Cancer Stage 2 and 3 Interventions: Drug: Fenofibrate; Other: Placebo; Drug: Doxorubicin; Drug: Cyclophosphamide Sponsors: Tanta University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials